Jazz Pharmaceuticals

$168.04
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.70 (-1.58%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell JAZZ and other stocks, options, and ETFs commission-free!

About JAZZ

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland. The listed name for JAZZ is Jazz Pharmaceuticals plc Common Stock (Ireland).

CEO
Bruce C. Cozadd
Employees
1,940
Headquarters
Dublin, Dublin
Founded
2003
Market Cap
8.73B
Price-Earnings Ratio
39.80
Dividend Yield
—
Average Volume
820.13K
High Today
$171.79
Low Today
$166.96
Open Price
$171.00
Volume
734.27K
52 Week High
$178.64
52 Week Low
$86.88

JAZZ News

BenzingaFeb 26

Canopy Growth Corp, GW Pharma, Jazz Pharmaceuticals - Item 9 Labs and Why Franchising is the Growth Vehicle to Propel the Cannabis Industry

Item 9 Labs Corp. is a sponsor and will speak at the Benzinga Cannabis Capital Conference set to take place on February 25-26, 2021. The information contained i
BenzingaFeb 23

Recap: Jazz Pharmaceuticals Q4 Earnings

Shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share dec

JAZZ Earnings

$0.45
$1.77
$3.10
$4.42
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
$4.20 per share
Actual
$4.00 per share
Replay Earnings Call

You May Also Like

CBPO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure